. During infection, C. difficile produces two key virulence determinants, toxin A and toxin B. Experiments with purified toxins have indicated that toxin A alone is able to evoke the symptoms of C. difficile infection, but toxin B is unable to do so unless it is mixed with toxin A or there is prior damage to the gut mucosa 3 . However, a recent study indicated that toxin B is essential for C. difficile virulence and that a strain producing toxin A alone was avirulent 4 . This creates a paradox over the individual importance of toxin A and toxin B. Here we show that isogenic mutants of C. difficile producing either toxin A or toxin B alone can cause fulminant disease in the hamster model of infection. By using a gene knockout system 5, 6 to inactivate the toxin genes permanently, we found that C. difficile producing either one or both toxins showed cytotoxic activity in vitro that translated directly into virulence in vivo. Furthermore, by constructing the first ever double-mutant strain of C. difficile, in which both toxin genes were inactivated, we were able to completely attenuate virulence. Our findings re-establish the importance of both toxin A and toxin B and highlight the need to continue to consider both toxins in the development of diagnostic tests and effective countermeasures against C. difficile.
Toxin A and toxin B both catalyse the glucosylation, and hence inactivation, of Rho-GTPases: small regulatory proteins of the eukaryotic actin cell cytoskeleton. This leads to disorganization of the cell cytoskeleton and cell death 7 . The toxin genes tcdA and tcdB are situated on the C. difficile chromosome in a 19.6-kilobase (kb) pathogenicity locus (PaLoc), along with the three accessory genes tcdC, tcdR and tcdE (Fig. 1a) . To address the individual importance of toxin A and toxin B, we used the ClosTron gene knockout system 6 to inactivate the toxin genes of C. difficile. This system inactivates genes by inserting an intron into the protein-encoding DNA sequence of a gene, thus resulting in a truncated and non-functional protein. The intron sequence itself encompasses an erythromycin-resistance determinant that permits selective isolation of mutants. Furthermore, it has been shown experimentally that the insertions are completely stable, meaning that inactivation of a gene is permanent 5 . Using the ClosTron system, we targeted insertions to tcdA and tcdB at nucleotide positions 1584 and 1511, respectively (Fig. 1a) . In both cases, this placed the intron within DNA sequence encoding the toxin catalytic domain. Three separate isogenic mutants of the toxin-A-positive, toxin-B-positive (A (Fig. 1d) . Subsequently, in vitro cell cytotoxicity assays were carried out using HT29 (human colon carcinoma) cells and Vero (African green monkey kidney) cells. Each of these cell lines is susceptible to both toxin A and toxin B, although HT29 cells are more sensitive to toxin A and Vero cells are more sensitive to toxin B 9 . The action of toxin A and toxin B causes the cells to 'round' (that is, lose morphology) and die; a phenomenon that is clearly visible by light microscopy. We incubated *These authors contributed equally to this work. cultured cells for 24 h with fourfold dilution series of C. difficile culture supernatants. To obtain the most objective data set possible, we determined the end-point titre of each dilution series, rather than implementing a subjective cell-scoring system. End-point titre was defined as the first dilution in a series for which HT29 or Vero cell morphology was indistinguishable from the negative controls (cells that had been incubated with uninoculated C. difficile culture medium).
As expected, the A 2 B 2 double-toxin mutant did not have any cytotoxic activity towards either HT29 or Vero cells (Fig. 2a, b) . Compared to the A 1 B 1 parental strain, the A 2 B 1 mutant showed reduced toxicity towards HT29 cells, although the difference was not statistically significant, and a similar degree of toxicity towards Vero cells (Fig. 2a,  b) . These findings were anticipated given the respective sensitivities of HT29 cells and Vero cells to toxin A and toxin B 9 . However, unexpectedly, when compared to the A 1 B 1 parental strain, the A 1 B 2 mutant showed increased toxicity towards HT29 cells, although the difference was not statistically significant, and a similar degree of toxicity towards Vero cells (Fig. 2a, b) . We reasoned that this may occur owing to increased expression of toxin A by the A
To confirm that the cytotoxic activity we had observed on HT29 cells and Vero cells was indeed attributable to the respective actions of toxin A and toxin B, we carried out toxin neutralization assays. Culture supernatants of each C. difficile toxin mutant and the A 1 B 1 parental strain were incubated with either toxin-A-specific or toxin-B-specific neutralizing antibodies before inoculation onto HT29 and Vero cell monolayers. Importantly, culture supernatants were diluted equivalently such that, for the A 1 B 1 parental strain, only toxin A activity was detected on HT29 cells and only toxin B activity was detected on Vero cells (that is, toxin B activity towards HT29 cells was diluted out completely and toxin A activity towards Vero cells was diluted out completely) (Fig. 2c, d ). As expected, the toxin-A-specific antibody neutralized all toxic activity produced by the A 1 B 2 mutant and the toxin-B-specific antibody neutralized all toxic activity produced by the A 2 B 1 mutant (Fig. 2c, d) . Interestingly, the increased production of toxin A by the A 1 B 2 mutant was clearly visible in this assay, as the cytotoxic activity of this strain towards Vero cells was not diluted out completely, as it was for the A 1 B 1 parental strain (Fig. 2d) . Having fully characterized our C. difficile toxin mutants in vitro, we tested the virulence of each in the hamster model of infection. Hamsters were each challenged with 100 spores of a single C. difficile strain, 5 days after an oral dose of clindamycin (30 mg kg (Fig. 3b) . In contrast, none of the hamsters colonized by the toxin-null A 2 B 2 double mutant developed any symptoms of disease during the 14-day experimental period, indicating that this strain is completely attenuated for virulence. Bacteriological and PCR analysis of caecum samples taken from each hamster post mortem confirmed that the only infecting strain of C. difficile was, indeed, the strain administered in every case, thus 
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ruling out any possibility of cross-contamination between cages or contamination from the environment (Supplementary Fig. 1 ).
In conclusion, it is clear that both toxin A and toxin B have an important role in C. difficile infection, because here we have shown that strains that produce either toxin on its own or both toxins together are virulent. It is pertinent to question why we found that an A 1 B 2 strain of C. difficile was virulent; a result that is in direct contrast with a similar study published recently 4 . This discrepancy may have arisen owing to inherent differences between the hamsters used in each study. However, perhaps more probable is that there is one or more key differences between the strains of C. difficile studied. Although both strains are erythromycin-sensitive derivatives of strain 630 (refs 10, 11), they were isolated independently through serial sub-culture 8, 12 . Therefore, either strain could have acquired one or more secondary mutations, which may affect the action of either one or both of the toxins. However, it is notable that our findings accord with those of previous studies that have suggested a role for both toxin A and toxin B in C. difficile infection 3, [13] [14] [15] . Moreover, given that the human colon is the principal site of pathology in patients infected with C. difficile, it stands to reason that an A 1 B 2 strain of C. difficile is virulent in vivo, as it is toxin A that shows the greatest cytotoxicity towards laboratorycultured HT29 cells. It is important to note that inherent variability exists between the toxins of some C. difficile strains, particularly in the case of toxin B [16] [17] [18] [19] . In practical terms, this means that the toxins from different strains can vary in enzymatic activity (that is, different GTPase substrates may be glucosylated) and/or host-cell specificity. Consequently, it is not appropriate to over-interpret our findings and make general conclusions about the toxins produced by all toxigenic strains of C. difficile. Nonetheless, our results clearly demonstrate that a strain of C. difficile producing either toxin A or toxin B alone may be virulent and thus we have re-established the importance of both toxins in C. difficile infection.
It is interesting to note that a number of clinical cases of C. difficile infection have been attributed to naturally occurring A isolates until now. This would suggest that A 1 B 2 strains do not exist, but it may also be an artefact of routine diagnostic testing practices. Either way, our results show that A 1 B 2 strains may be virulent and even if they do not exist in nature already, they may yet evolve. Consequently, it is imperative that both toxin A and toxin B continue to be considered in routine diagnostic settings and in the development of effective countermeasures against C. difficile.
METHODS SUMMARY
Mutants were constructed from the parental strain C. difficile 630Derm 8 using the ClosTron system 5, 6 . The retargeted plasmids pMTL007C-E2::Cdi-tcdA-1584s, pMTL007C-E2::Cdi-tcdB-1511a and, for the double mutant, pMTL007S-C7::Cdi-tcdA-1584s were transferred into C. difficile via conjugation. The single ClosTron mutants were isolated on erythromycin plates. The double mutant was isolated on thiamphenicol plates.
For cytotoxicity assays, the four strains were grown overnight in 5 ml TY (3% w/ v bacto-tryptose, 2% w/v yeast extract and 0.1% w/v thioglycolate, adjusted to pH 7.4) under anaerobic conditions as previously described 22 . The cell densities were standardized before centrifugation and filtration. Supernatants were diluted in a fourfold series and 20 ml of dilutions were added onto monolayers of Vero and HT29 cells preincubated in 96-well plates for 48 h (at 37 uC, 5% CO 2 ). Cytotoxicity was recorded after 24 h. Statistical analysis was performed using one-way ANOVA tests. For the neutralization assay, appropriate dilutions of supernatants were preincubated with a suitable concentration of anti-TcdA or anti-TcdB serum (polyclonal, tgcBIOMICS) for 1 h at 37 uC and then added onto cell monlayers of Vero and HT29 cells as described earlier and evaluated after 24 h. Golden Syrian hamsters were dosed with clindamycin (30 mg kg 21 ) 5 days before being infected orally with 100 spores each. Hamsters were monitored for signs of infection (including weight loss, behavioural changes and wet tail) and killed when the end point was met. Faecal pellets were collected daily and plated to confirm the presence or absence of C. difficile. Caecum samples were homogenized, plated and C. difficile counts obtained. PCR was performed to determine the C. difficile genotype isolated from all samples. See Supplementary Information for PCR results.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
